Tower Research Capital LLC (Trc) Altimmune, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Altimmune, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 26,960 shares of ALT stock, worth $222,420. This represents 0.0% of its overall portfolio holdings.

Number of Shares

26,960

Previous 20,591 30.93%

Holding current value

$222,420

Previous $136,000 21.32%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$5.5 - $8.1 $35,029 - $51,588	6,369 Added 30.93%	26,960 $165,000
Q2 2024 Aug 13, 2024	BUY	$5.91 - $10.23 $58,544 - $101,338	9,906 Added 92.71%	20,591 $136,000
Q1 2024 May 15, 2024	BUY	$8.22 - $13.81 $764 - $1,284	93 Added 0.88%	10,685 $108,000
Q4 2023 Feb 13, 2024	BUY	$2.14 - $11.62 $9,473 - $51,441	4,427 Added 71.81%	10,592 $119,000
Q3 2023 Nov 14, 2023	SELL	$2.4 - $3.45 $49,420 - $71,042	-20,592 Reduced 76.96%	6,165 $16,000
Q2 2023 Aug 14, 2023	BUY	$3.45 - $5.97 $22,990 - $39,784	6,664 Added 33.17%	26,757 $94,000
Q1 2023 May 09, 2023	SELL	$4.19 - $16.83 $38,606 - $155,071	-9,214 Reduced 31.44%	20,093 $85,000
Q4 2022 Feb 10, 2023	BUY	$8.74 - $16.45 $1,494 - $2,812	171 Added 0.59%	29,307 $482,000
Q3 2022 Nov 10, 2022	BUY	$10.67 - $22.41 $246,455 - $517,626	23,098 Added 382.54%	29,136 $373,000
Q2 2022 Aug 15, 2022	SELL	$3.94 - $11.77 $46,440 - $138,732	-11,787 Reduced 66.13%	6,038 $71,000
Q1 2022 May 12, 2022	SELL	$5.9 - $9.45 $40,444 - $64,779	-6,855 Reduced 27.78%	17,825 $108,000
Q4 2021 Feb 14, 2022	BUY	$8.69 - $12.48 $169,837 - $243,909	19,544 Added 380.53%	24,680 $226,000
Q3 2021 Nov 15, 2021	SELL	$8.43 - $16.81 $150,045 - $299,201	-17,799 Reduced 77.61%	5,136 $58,000
Q2 2021 Aug 16, 2021	BUY	$9.85 - $16.46 $190,942 - $319,077	19,385 Added 546.06%	22,935 $226,000
Q1 2021 May 17, 2021	BUY	$12.71 - $24.31 $30,732 - $58,781	2,418 Added 213.6%	3,550 $51,000
Q4 2020 Feb 16, 2021	SELL	$7.84 - $14.22 $3,206 - $5,815	-409 Reduced 26.54%	1,132 $13,000
Q3 2020 Nov 16, 2020	BUY	$9.93 - $33.26 $12,392 - $41,508	1,248 Added 425.94%	1,541 $20,000
Q2 2020 Aug 13, 2020	BUY	$2.9 - $10.71 $849 - $3,138	293 New	293 $3,000

Others Institutions Holding ALT

# of Institutions

186

Shares Held

39.3M

Call Options Held

913K

Put Options Held

743K

View Full List

About Altimmune, Inc.

Ticker ALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,025,300
Market Cap $404M
Description
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...

More about ALT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Altimmune, Inc. Transaction History